Meta Biomed Co. Ltd Market Cap ($56.20 Million)
Market Cap & Net Worth: Meta Biomed Co. Ltd (059210)
Meta Biomed Co. Ltd market cap. Meta Biomed Co. Ltd (KQ:059210) has a market capitalization of $56.20 Million (₩82.93 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21240 globally and #1240 in its home market, demonstrating a -1.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Meta Biomed Co. Ltd's stock price ₩3530.00 by its total outstanding shares 23492400 (23.49 Million). Also see Meta Biomed Co. Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Meta Biomed Co. Ltd Market Cap History (2015–2026)
Meta Biomed Co. Ltd market cap history from 2015 to 2026. Data shows change from $64.43 Million to $56.20 Million (-2.86% CAGR). Check Meta Biomed Co. Ltd stock price for real-time trading data and today's change.
Index Memberships
Meta Biomed Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.03% | #565 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.03% | #565 of 1384 |
Weight: Meta Biomed Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Meta Biomed Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Meta Biomed Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 059210 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Meta Biomed Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Meta Biomed Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $64.43 Million | $68.59 Billion | $805.65 Million | 0.00x | 0.08x |
| 2016 | $74.18 Million | $65.78 Billion | $638.90 Million | 0.00x | 0.12x |
| 2017 | $53.97 Million | $65.34 Billion | -$4.10 Billion | 0.00x | N/A |
| 2018 | $45.42 Million | $52.59 Billion | -$1.15 Billion | 0.00x | N/A |
| 2019 | $43.26 Million | $59.39 Billion | $3.35 Billion | 0.00x | 0.01x |
| 2020 | $43.81 Million | $47.21 Billion | -$4.09 Billion | 0.00x | N/A |
| 2021 | $45.40 Million | $58.78 Billion | $9.52 Billion | 0.00x | 0.00x |
| 2022 | $36.60 Million | $68.94 Billion | $2.63 Billion | 0.00x | 0.01x |
| 2023 | $69.41 Million | $83.10 Billion | $10.08 Billion | 0.00x | 0.01x |
| 2024 | $59.06 Million | $94.04 Billion | $22.40 Billion | 0.00x | 0.00x |
Competitor Companies of 059210 by Market Capitalization
Companies near Meta Biomed Co. Ltd in the global market cap rankings as of November 4, 2026. Also see Meta Biomed Co. Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Meta Biomed Co. Ltd by market ranking:
- InBody Co.Ltd (KQ:041830): Ranked #12728 globally with a market cap of $424.41 Million USD ( ₩626.27 Billion KRW).
- INFINITT Healthcare Co. Ltd (KQ:071200): Ranked #16564 globally with a market cap of $187.66 Million USD ( ₩276.92 Billion KRW).
- MEDIANA Co.Ltd (KQ:041920): Ranked #22138 globally with a market cap of $44.69 Million USD ( ₩65.94 Billion KRW).
- Value Added Technology Co. Ltd (KQ:043150): Ranked #17094 globally with a market cap of $164.85 Million USD ( ₩243.26 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12728 | InBody Co.Ltd | KQ:041830 | $424.41 Million | ₩46450.00 |
| #16564 | INFINITT Healthcare Co. Ltd | KQ:071200 | $187.66 Million | ₩11360.00 |
| #22138 | MEDIANA Co.Ltd | KQ:041920 | $44.69 Million | ₩7700.00 |
| #17094 | Value Added Technology Co. Ltd | KQ:043150 | $164.85 Million | ₩16600.00 |
Market Capitalization of Meta Biomed Co. Ltd (2015–2026)
Market capitalization of Meta Biomed Co. Ltd from 2015 to today. Between 2015 and today, Meta Biomed Co. Ltd's market cap moved from $64.43 Million to $ 56.20 Million, with a yearly change of -2.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩56.20 Million | -28.97% |
| 2025 | ₩79.12 Million | +33.96% |
| 2024 | ₩59.06 Million | -14.91% |
| 2023 | ₩69.41 Million | +89.65% |
| 2022 | ₩36.60 Million | -19.39% |
| 2021 | ₩45.40 Million | +3.63% |
| 2020 | ₩43.81 Million | +1.27% |
| 2019 | ₩43.26 Million | -4.75% |
| 2018 | ₩45.42 Million | -15.84% |
| 2017 | ₩53.97 Million | -27.25% |
| 2016 | ₩74.18 Million | +15.14% |
| 2015 | ₩64.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Meta Biomed Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $56.20 Million USD |
| MoneyControl | $56.20 Million USD |
| MarketWatch | $56.20 Million USD |
| marketcap.company | $56.20 Million USD |
| Reuters | $56.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Meta Biomed Co. Ltd
Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone product… Read more